LexDanaLexDanabeta
Inventor

David D. Ho

Inventor
Chappaqua, NY, US

Overview

19→
Patents
1993–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07KPeptides24%
C07HSugars9%
C12NMicroorganisms or enzymes4%
G06FElectric digital data processing4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
PatentTitleYear
10,654,943Tri-specific antibodies for HIV therapy202010,308,707Bispecific HIV-1-neutralizing antibodies20199,884,905'Bispecific HIV-1 neutralizing antibodies'20189,790,276'Glycan-modified anti-CD4 antibodies for HIV prevention and therapy'20179,587,022'Glycan-modified anti-CD4 antibody with improved HIV-1 neutralizing activity'20179,587,012'Bispecific HIV-1 neutralizing antibodies'20178,637,024'Fusion antibodies for HIV therapy'20148,586,051'Glycolipids and analogues thereof as antigens for NKT cells'20138,163,290'Glycolipids and analogues thereof as antigens for NKT cells'20128,030,029'Flu vaccines and methods of use thereof'20117,981,428'Flu vaccines and methods of use thereof'20117,923,013'Glycolipids and analogues thereof as antigens for NKT cells'20117,534,434'Glycolipids and analogues thereof as antigens for NK T cells'20096,714,906'Rapid phase identification method'20046,298,343'Methods for intelligent universal database search engines'20016,235,504'Methods for identifying genomic equivalent markers and their use in quantitating cells and polynucleotide sequences therein'20016,190,871'Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) gp120 and methods of use'20016,054,284'Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use'20005,178,865'Chinese herbal extracts in the treatment of HIV related disease in vitro'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2001Patents assigned to CEDARS SINAI MEDICAL CENTER (3)· patent assignee history
2000Based in Capaqua, NY, US· patent location history
2001–2020Patents assigned to UNIV ROCKEFELLER (11)· patent assignee history
2001–2020Based in Chappaqua, NY, US· patent location history
2001–2004Based in Chung-Ho, TW· patent location history
2001Based in Chapaqua, NY, US· patent location history
2009–2014Based in New York, NY, US· patent location history
2011–2013Patents assigned to SCRIPPS RESEARCH INST (3)· patent assignee history
2011Patents assigned to ACADEMIA SINICA (2)· patent assignee history
2017–2019Patents assigned to AARON DIAMOND AIDS RES CENTER (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV ROCKEFELLER112001–2020
AARON DIAMOND AIDS RES CENTER32017–2019
CEDARS SINAI MEDICAL CENTER31993–2001
SCRIPPS RESEARCH INST32011–2013
ACADEMIA SINICA22011
Locations
LocationPatentsSpan
Chappaqua, New York, US82001–2020
New York, New York, US62009–2014
Chung-Ho, TW22001–2004
Chapaqua, New York, US12001
Capaqua, New York, US12000